Stock Information
Nektar Therapeutics (NKTR)
Ticker Symbol: NKTR
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,566.10 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -9.8084
Revenue (TTM): $2.72 M
Dividend Yield: N/A%
ROE: -184.69%
Latest News
-
Piper Sandler Maintains Overweight on Nektar Therapeutics, Raises Price Target to $192
Fri, May 8, 2026 11:09 AM
-
Nektar Therapeutics (NKTR) Q1 2026 Earnings Call Transcript
Fri, May 8, 2026 5:11 AM
-
Transcript : Nektar Therapeutics, Q1 2026 Earnings Call, May 07, 2026
Fri, May 8, 2026 5:05 AM
-
NEKTAR THERAPEUTICS (NASDAQ:NKTR) Q1 Earnings Beat Revenue Estimates but EPS Miss Drags Stock Lower
Thu, May 7, 2026 11:55 PM
-
Nektar: Q1 Earnings Snapshot
Thu, May 7, 2026 5:19 PM
-
Nektar Therapeutics Q1 EPS $(1.82) Misses $(1.62) Estimate, Sales $10.860M Beat $10.636M Estimate
Thu, May 7, 2026 4:16 PM
-
Nektar Therapeutics Reports First Quarter 2026 Financial Results
Thu, May 7, 2026 4:16 PM
-
Nektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still Cheap
Tue, May 5, 2026 10:24 AM
-
NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
Mon, May 4, 2026 12:29 PM
-
NKTR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
Sat, May 2, 2026 8:08 AM
Key Financials
Financial data not available
